de Invesco CVS Health CVS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 2131 M | Vender |
20,595,431
-4,543,515
| -18% | -USD 406 M | 0.17% | 95 |
|
|
2026
Q1 | USD 1805 M | Comprar |
25,138,946
+1,119,805
| +5% | +USD 86.3 M | 0.18% | 95 |
|
|
2025
Q4 | USD 1906 M | Vender |
24,019,141
-273,917
| -1% | -USD 21.6 M | 0.18% | 92 |
|
|
2025
Q3 | USD 1831 M | Comprar |
24,293,058
+760,579
| +3% | +USD 52.1 M | 0.29% | 43 |
|
|
2025
Q2 | USD 1623 M | Comprar |
23,532,479
+3,118,626
| +15% | +USD 204 M | 0.28% | 48 |
|
|
2025
Q1 | USD 1383 M | Comprar |
20,413,853
+2,375,764
| +13% | +USD 142 M | 0.26% | 55 |
|
|
2024
Q4 | USD 810 M | Comprar |
18,038,089
+4,173,243
| +30% | +USD 234 M | 0.15% | 135 |
|
|
2024
Q3 | USD 872 M | Comprar |
13,864,846
+1,774,453
| +15% | +USD 104 M | 0.17% | 120 |
|
|
2024
Q2 | USD 714 M | Vender |
12,090,393
-2,546,382
| -17% | -USD 159 M | 0.15% | 136 |
|
|
2024
Q1 | USD 1167 M | Vender |
14,636,775
-1,323,283
| -8% | -USD 101 M | 0.25% | 61 |
|
|
2023
Q4 | USD 1260 M | Vender |
15,960,058
-135,832
| -0.8% | -USD 9.7 M | 0.3% | 44 |
|
|
2023
Q3 | USD 1124 M | Vender |
16,095,890
-906,597
| -5% | -USD 64.2 M | 0.3% | 40 |
|
|
2023
Q2 | USD 1175 M | Comprar |
17,002,487
+1,605,878
| +10% | +USD 114 M | 0.31% | 41 |
|
|
2023
Q1 | USD 1144 M | Vender |
15,396,609
-279,629
| -2% | -USD 23.4 M | 0.32% | 42 |
|
|
2022
Q4 | USD 1461 M | Vender |
15,676,238
-1,473,754
| -9% | -USD 142 M | 0.43% | 22 |
|
|
2022
Q3 | USD 1636 M | Comprar |
17,149,992
+393,212
| +2% | +USD 38.9 M | 0.53% | 15 |
|
|
2022
Q2 | USD 1553 M | Vender |
16,756,780
-576,761
| -3% | -USD 56.3 M | 0.47% | 21 |
|
|
2022
Q1 | USD 1754 M | Vender |
17,333,541
-358,250
| -2% | -USD 37.6 M | 0.45% | 21 |
|
|
2021
Q4 | USD 1825 M | Vender |
17,691,791
-319,776
| -2% | -USD 29.5 M | 0.44% | 25 |
|
|
2021
Q3 | USD 1528 M | Comprar |
18,011,567
+4,645,402
| +35% | +USD 389 M | 0.39% | 34 |
|
|
2021
Q2 | USD 1115 M | Comprar |
13,366,165
+190,018
| +1% | +USD 15.6 M | 0.27% | 51 |
|
|
2021
Q1 | USD 991 M | Comprar |
13,176,147
+304,146
| +2% | +USD 22.2 M | 0.26% | 57 |
|
|
2020
Q4 | USD 879 M | Comprar |
12,872,001
+2,535,317
| +25% | +USD 165 M | 0.26% | 67 |
|
|
2020
Q3 | USD 604 M | Vender |
10,336,684
-592,849
| -5% | -USD 36.9 M | 0.2% | 98 |
|
|
2020
Q2 | USD 710 M | Comprar |
10,929,533
+643,745
| +6% | +USD 40.5 M | 0.25% | 79 |
|
|
2020
Q1 | USD 610 M | Vender |
10,285,788
-1,287,468
| -11% | -USD 85.9 M | 0.26% | 82 |
|
|
2019
Q4 | USD 860 M | Vender |
11,573,256
-524,092
| -4% | -USD 36.8 M | 0.27% | 70 |
|
|
2019
Q3 | USD 763 M | Comprar |
12,097,348
+888,655
| +8% | +USD 52.7 M | 0.2% | 100 |
|
|
2019
Q2 | USD 611 M | Comprar |
11,208,693
+638,593
| +6% | +USD 34.4 M | 0.16% | 139 |
|
|
2019
Q1 | USD 570 M | Vender |
10,570,100
-2,319,211
| -18% | -USD 143 M | 0.19% | 116 |
|
|
2018
Q4 | USD 845 M | Vender |
12,889,311
-253,465
| -2% | -USD 18.9 M | 0.32% | 54 |
|
|
2018
Q3 | USD 1035 M | Comprar |
13,142,776
+628,294
| +5% | +USD 44.9 M | 0.33% | 54 |
|
|
2018
Q2 | USD 805 M | Comprar |
12,514,482
+2,000,042
| +19% | +USD 132 M | 0.27% | 71 |
|
|
2018
Q1 | USD 654 M | Comprar |
10,514,440
+859,754
| +9% | +USD 61.7 M | 0.24% | 85 |
|
|
2017
Q4 | USD 700 M | Comprar |
9,654,686
+2,482,593
| +35% | +USD 180 M | 0.25% | 81 |
|
|
2017
Q3 | USD 583 M | Comprar |
7,172,093
+335,334
| +5% | +USD 26.5 M | 0.22% | 102 |
|
|
2017
Q2 | USD 550 M | Comprar |
6,836,759
+3,426,341
| +100% | +USD 271 M | 0.17% | 127 |
|
|
2017
Q1 | USD 268 M | Vender |
3,410,418
-1,154,003
| -25% | -USD 92.1 M | 0.09% | 248 |
|
|
2016
Q4 | USD 360 M | Comprar |
4,564,421
+547,737
| +14% | +USD 44.3 M | 0.12% | 183 |
|
|
2016
Q3 | USD 357 M | Comprar |
4,016,684
+584,723
| +17% | +USD 55.2 M | 0.12% | 189 |
|
|
2016
Q2 | USD 329 M | Vender |
3,431,961
-559,962
| -14% | -USD 55.8 M | 0.12% | 188 |
|
|
2016
Q1 | USD 414 M | Vender |
3,991,923
-610,735
| -13% | -USD 59.4 M | 0.17% | 139 |
|
|
2015
Q4 | USD 450 M | Vender |
4,602,658
-1,214,517
| -21% | -USD 119 M | 0.18% | 117 |
|
|
2015
Q3 | USD 561 M | Vender |
5,817,175
-62,678
| -1% | -USD 6.59 M | 0.24% | 85 |
|
|
2015
Q2 | USD 617 M | Comprar |
5,879,853
+1,201,552
| +26% | +USD 123 M | 0.24% | 83 |
|
|
2015
Q1 | USD 483 M | Vender |
4,678,301
-1,052,779
| -18% | -USD 107 M | 0.19% | 116 |
|
|
2014
Q4 | USD 552 M | Vender |
5,731,080
-2,751,488
| -32% | -USD 242 M | 0.21% | 103 |
|
|
2014
Q3 | USD 675 M | Comprar |
8,482,568
+388,519
| +5% | +USD 30.6 M | 0.27% | 69 |
|
|
2014
Q2 | USD 610 M | Vender |
8,094,049
-162,411
| -2% | -USD 12.3 M | 0.24% | 82 |
|
|
2014
Q1 | USD 618 M | Vender |
8,256,460
-1,135,102
| -12% | -USD 80.2 M | 0.25% | 74 |
|
|
2013
Q4 | USD 672 M | Comprar |
9,391,562
+36,009
| +0.4% | +USD 2.31 M | 0.27% | 69 |
|
|
2013
Q3 | USD 531 M | Vender |
9,355,553
-263,542
| -3% | -USD 15.7 M | 0.23% | 90 |
|
|
2013
Q2 | USD 550 M | Comprar |
+9,619,095
| Nuevas | +USD 557 M | 0.26% | 81 |
|
Otros fondos que tienen CVS en su cartera
Posición de Invesco en CVS: resumen de T2 2026
Invesco redujo su participación en CVS Health (CVS) en 18% durante T2 2026, al vender acciones por un valor estimado de USD 406 M, y conservó 20,595,431 acciones valuadas en USD 2131 M. La posición representa 0.17% de la cartera y ocupa el puesto #95.
Invesco reportó por primera vez una posición en CVS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 2,078 fondos que sigue Wall St. Rank mantienen una posición en CVS.
- Al cierre de T2 2026, Invesco tenía 20,595,431 acciones de CVS Health con un valor de USD 2131 M.
- Invesco vendió 4,543,515 acciones de CVS Health en T2 2026, por un valor estimado de USD 406 M.
- CVS Health representó 0.17% de la cartera de Invesco en T2 2026 y fue su posición número 95.
- Invesco reportó por primera vez una posición en CVS Health en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 2,078 fondos que sigue Wall St. Rank tenían CVS Health en cartera.
Según el Informe 13F de Invesco correspondiente a T2 2026, presentado el 14 ago 2026.